US Stocks
Avidity Biosciences Inc
Avidity Biosciences Inc

Avidity Biosciences Inc (RNA)


  • $







Key Stats

Today Low/High$21.67 / $22.14
52 Week Low/High$17.58 / $36.02
Market Cap$826.48M

Company Details

Avidity Biosciences, Inc. is driven to change lives with a new class of therapies called Antibody Oligonucleotide Conjugates (AOCs) that are designed to overcome current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Avidity's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. Avidity's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, and its other muscle programs are focused on the treatment of Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, Pompe disease and muscle atrophy. In addition to its muscle franchise, Avidity has research efforts focused on immune, cardiac and other cell types.
OrganisationAvidity Biosciences Inc
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Avidity Biosciences Inc (RNA) share price today?

Can Indians buy Avidity Biosciences Inc (RNA) shares?

How can I buy Avidity Biosciences Inc (RNA) shares from India?

Can Fractional shares of Avidity Biosciences Inc (RNA) be purchased?

What are the documents required to start investing in Avidity Biosciences Inc (RNA) stocks?

We are a SEBI registered investement advisor